Pfizer Inc vs First Trust NASDAQ Clean Edge Green Energy Idx Fd — how do they compare? Pfizer Inc trades at $28.21 (market cap $158.56B), while First Trust NASDAQ Clean Edge Green Energy Idx Fd trades at $47.94 (market cap $561.25M). The key difference: Pfizer Inc is far larger — about 282.5× First Trust NASDAQ Clean Edge Green Energy Idx Fd's market cap, and Pfizer Inc pays a 6.18% dividend while First Trust NASDAQ Clean Edge Green Energy Idx Fd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Pfizer Inc for 158 Days and First Trust NASDAQ Clean Edge Green Energy Idx Fd for 50 Days on average.
| PFE | QCLN | |
|---|---|---|
Market Cap | $158.56B | $561.25M |
Volume | 44,138,282 | 323,550 |
Sector | Health | Sector/Thematic |
52-Week High | $29.02 | $68.47 |
52-Week Low | $23.67 | $41.10 |
Typical Hold Time | 158 Days | 50 Days |
Enterprise Value | $210.06B | — |
Dividend Yield | 6.18% | — |
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $28.00, up 1.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $62.58 billion in 2025 with a net income margin of 6.8%, and has beaten EPS estimates for the last three quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline as key growth drivers in 2026.
The stock presents a value opportunity with a consensus price target of $29.17, but faces risks from patent expirations and projected earnings decline. Investor sentiment is mixed, with analysts largely neutral, emphasizing the stock's defensive cash flow and dividend yield amid ongoing business transformation.
QCLN trades at $49.44, down 2.62% today but maintains a bullish technical outlook with strong moving average support. The clean energy ETF benefits from geopolitical tensions accelerating renewable energy adoption globally. Recent news highlights increased data center energy demand and political focus on clean energy policies as key growth catalysts.
The ETF's performance remains tied to U.S. political outcomes and federal energy policy, with recent outperformance against major indices. Key risks include policy uncertainty and market volatility, while institutional interest grows amid global energy security concerns and the ongoing energy transition.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →QCLN invests in U.S.-listed companies engaged in clean energy technologies. It focuses on solar power, wind, electric vehicles, and energy storage, with major holdings in firms like Tesla, ON Semiconductor, and Rivian.
Read more on QCLN →